Our Innovation

EKA-15 KS-PU:
Peptide Innovation
Platform

A next-generation biodegradable peptide technology designed to address antifungal resistance challenges.

Technology Overview

How the Technology Works

EKA-15 KS-PU is designed using peptide-based mechanisms inspired by natural biological systems. The platform focuses on targeted antifungal interaction pathways while aiming to reduce environmental impact and resistance concerns associated with conventional fungicides.

EKA-15 KS-PU peptide mechanism — antifungal technology targeting fungal membranes

Why it Matters

Challenges with Conventional Fungicides

Traditional fungicides often face:

01
Resistance Development
Prolonged use of conventional chemical fungicides leads to resistance buildup in fungal populations, reducing long-term efficacy and demanding ever-increasing dosages.
02
Environmental Residue Concerns
Chemical residues persist in soil and water systems, raising serious concerns about ecosystem health, food safety, and regulatory compliance across global markets.
03
Broad-Spectrum Toxicity
Many conventional fungicides lack specificity, harming beneficial microorganisms, pollinators, and non-target organisms alongside the intended fungal pathogens.
04
Sustainability Limitations
As global demand for environmentally responsible agriculture grows, chemical-heavy approaches face mounting pressure from regulators, consumers, and sustainability mandates.

Sarpada Bioinnovate aims to support the transition toward safer and more sustainable biotechnology solutions.

Comparison

EKA-15 KS-PU vs. Conventional Fungicides

Dimension Conventional Fungicides EKA-15 KS-PU
Base Chemical-heavy Nature-inspired peptide platform
Residue Residue concerns Biodegradable approach
Resistance Resistance buildup Lower resistance risk potential
Toxicity Broad toxicity Target-focused innovation

Application Areas

Where Innovation Meets Impact

Agriculture

Sustainable crop protection applications and future agricultural resilience strategies.

Future Biomedical Potential

Long-term exploration of peptide-based innovation pathways in healthcare and antimicrobial technologies.

Development Stage

Current Development Status

01
Patent Filed
Intellectual property foundation secured for the EKA-15 KS-PU platform.
02
Research & Validation Ongoing
Active scientific research to validate efficacy and refine the platform.
03
Open for Pilot Collaborations
Inviting research partners and institutions for early-stage collaborative pilots.
04
Seeking Strategic Partnerships
Exploring licensing opportunities and strategic industry partnerships.

Protected Innovation

Intellectual Property

The innovation is supported through intellectual property development focused on protecting and advancing peptide-based biotechnology solutions. Patent status and research updates may be shared with authorized collaborators and partners where applicable.

Patent Filed
Application No. 202511054408

Interested in Collaboration?

We welcome opportunities for scientific collaboration, research partnerships, investment discussions, and industry engagement.

Contact Our Team Partner With Us